Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Psychosis and schizophrenia in adults: prevention and management

Clinical guideline
Reference number: CG178
Published: 12 February 2014
Last updated: 18 March 2014

Evidence

Supporting evidence

Surveillance report
2023 exceptional surveillance of psychosis and schizophrenia in children, young people and adults (NICE guidelines CG155 and CG178)
Appendix A: PICO table for weight management searches (PDF 305 KB)

Published:

02 November 2023
Appendix B: Summary of evidence (PDF 398 KB)

Published:

02 November 2023
2021 exceptional surveillance of testing for diabetes (NICE guidelines CG178, CG185, CG155, CG158 and NG185)
Appendix A: Changes to recommendations on testing for diabetes across NICE guidelines (PDF 143 KB)

Published:

08 September 2021
2019 exceptional surveillance of psychosis and schizophrenia in adults: prevention and management (NICE guideline CG178)
Surveillance report 2017 – Psychosis and schizophrenia in adults: prevention and management (2014) NICE guideline CG178
Appendix A: Summary of evidence from surveillance (PDF 1.03 MB)

Published:

09 November 2017
Appendix B: Stakeholder consultation comments table (PDF 577 KB)

Published:

09 November 2017
Full guidance
Full guideline (PDF 9.68 MB)

Published:

12 February 2014
Appendices 1-12 (PDF 971 KB)

Published:

12 February 2014
Appendix 13 (PDF 565 KB)

Published:

12 February 2014
Appendix 14 (PDF 342 KB)

Published:

12 February 2014
Appendix 15a (Excel 642 KB)

Published:

12 February 2014
Appendix 15b (PDF 629 KB)

Published:

12 February 2014
Appendix 16 (PDF 1.97 MB)

Published:

12 February 2014
Appendix 17 (PDF 1.04 MB)

Published:

12 February 2014
Appendix 18 (PDF 353 KB)

Published:

12 February 2014
Appendix 19 (PDF 254 KB)

Published:

12 February 2014
Appendix 20 (PDF 444 KB)

Published:

12 February 2014
Appendix 21 (PDF 492 KB)

Published:

12 February 2014
Appendix 22a (PDF 506 KB)

Published:

12 February 2014
Appendix 22b (PDF 2.55 MB)

Published:

12 February 2014
Appendix 22c (PDF 2.6 MB)

Published:

12 February 2014
Appendix 23a (PDF 246 KB)

Published:

12 February 2014
Appendix 23b (PDF 144 KB)

Published:

12 February 2014
Appendix 23c (PDF 4.57 MB)

Published:

12 February 2014
Appendix 23d (PDF 4.28 MB)

Published:

12 February 2014
Appendix 24 (PDF 433 KB)

Published:

12 February 2014
Appendix 25 (PDF 639 KB)

Published:

12 February 2014
Appendix 26 (PDF 470 KB)

Published:

12 February 2014
Appendix 27 (PDF 3.53 MB)

Published:

12 February 2014
Appendix 28 (PDF 434 KB)

Published:

12 February 2014